An important study was recently published looking at face mask coverings and the spread of COVID-19.
poverty-action.org/publicati…
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM nejm.org/doi/full/10.1056/NE…
Recruit for #ICECAP at AAH sites begins this week. Interesting to see how the trial will compare to TTM2. Today’s presentation maybe practice changing for many. #TTM2trial
Will await the final print but RECOVERY trial demonstrates improved outcomes in those receiving tocilizumab. This is consistent with prior trials as well as trials using both toci and dexamethasone. medrxiv.org/content/10.1101/…
David Barounis MD retweeted
There is an enormous demonstration going on at @Stanford Hospital right now carried out by staff, who are protesting the decision by higher ups to give vaccines to some administrators and physicians who are at home and not in contact with patients INSTEAD of frontline workers.
His work was mission critical, may his family and friends take some comfort in that.
RIP.
This might be the first U.K. anaesthetist COVID death. @doctimcook @dannyjnwong
David Barounis MD retweeted
Winter Panel Series opens this week with a discussion on EM Critical Care Wed @7pm
featuring
@DavidBarounis, ACMC grad and medical director of ICU
@jstancc, ACMC grad and intensivist
@ma5880 PGY3, Northwestern critical care fellowship bound
RSVP to [email protected]
Thank you to all the residents that helped out during the initial wave of patients in mid-March. Thank you to Dr. Mukai for giving this lecture at ICEP!
@ACMCEM @ACMCIMRes @advocatehealth
This Post is from an account that no longer exists. Learn more
Thank you @ACMCEM for allowing me to tell the evolving story about our experience with #covid19 So many people have been involved in keeping our patients safe while supporting each other through difficult times @advocatehealth @DoddMD @RajuMehtaMD @ngoodmanson
insightful (and at times incredible) presentation today from
@DavidBarounis reflecting on our first COVID surge at ACMC and lessons for the future (1/4)
#COVID #COVID19 #EmergencyMedicine #MedEd #EMed #TheACMCDifference
Early use of tocilizumab appears to show a reduction in a composite endpoint of mortality + need for mechanical ventilation. We’re working on RCT data now @DoddMD @AdvocateAurora @RajuMehtaMD thelancet.com/journals/lanrh…
1/2 Part of our strategy from the beginning has been looking at the implementation of steroids in patients with #COVID19. We followed the DEXA-ARDS trial, and after intense internal debate, we adopted the approach based on crude inflammatory markers and
2/2 development of hypoxemia. There is more to this story, but it is plausible this accounts for a portion of the results we have seen. Thank you to our AIP team!
@advocatehealth @RajuMehtaMD @DoddMD @ngoodmanson @ECMOeydelman @AdvocateAurora
Now let’s see the formal published results ASAP recoverytrial.net/files/reco…
More data supporting that routine chemical prophylaxis in critically ill patients with covid19 may be inadequate. Also interesting that their icu mortality is precisely the same as ours. @DoddMD @RajuMehtaMD #covid19 #covid19foam pdfs.journals.lww.com/ccmjou…














